ATPS-58 COMBINATION TYROSINE KINASE INHIBITORS EFFECTIVELY OVERCOME THE APOPTOSIS RESISTANCE, INVASIVE POTENTIAL AND ANGIOGENIC CAPACITY OF GLIOBLASTOMA MULTIFORME CELLS

Antzeko izenburuak

• A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme
  nork: Nehoff, Hayley, et al.
  Argitaratua: (2015)
• Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
  nork: Nehoff, Hayley, et al.
  Argitaratua: (2014)
• Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery – dual uptake through enterocytes and M-cells
  nork: Parayath, Neha N, et al.
  Argitaratua: (2015)
• ATPS-77 THE KETONE BODY ß-HYDROXYBUTYRATE RADIOSENSITIZES GLIOBLASTOMA MULTIFORME STEM CELLS
  nork: Silva-Nichols, Helena B., et al.
  Argitaratua: (2015)
• ATPS-60 COMPREHENSIVE IDENTIFICATION OF GLIOBLASTOMA MULTIFORME THERAPEUTIC TARGETS AND GROWTH SUPPRESSOR GENES USING GENE EDITING
  nork: Toledo, Chad, et al.
  Argitaratua: (2015)